Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

174.75
-3.6100-2.02%
Pre-market: 175.120.3700+0.21%08:55 EDT
Volume:1.96M
Turnover:345.82M
Market Cap:23.45B
PE:-49.88
High:180.91
Open:177.17
Low:173.96
Close:178.36
52wk High:183.51
52wk Low:60.45
Shares:134.20M
Float Shares:129.78M
Volume Ratio:1.13
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-105.22
PE(LYR):-52.63

Loading ...

Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT) and Guardant Health (GH)

TIPRANKS
·
Jul 03

Zydus Lifesciences Signs Mou with Apollo Hospitals

Reuters
·
Jul 03

Guardant Health: Buy Rating Reaffirmed as UnitedHealth Coverage Expands Shield Access; 12-Month Price Target Maintained at $165

TIPRANKS
·
Jul 02

Guardant news ‘meaningful positive’ but impact modest, says TD

TIPRANKS
·
Jul 02

When Multi-cancer Blood Screens Could Finally Take Off

Dow Jones
·
Jul 02

Unitedhealth Group NOW Covers Guardant Health’s Shield Blood Test for Colorectal Cancer Screening

THOMSON REUTERS
·
Jul 02

Guardant Health Rises on Unitedhealth Coverage Boost for Colorectal Cancer Kit

Reuters
·
Jul 02

Guardant Health is Maintained at Buy by BTIG

Dow Jones
·
Jul 02

Guardant Health price target raised to $190 from $160 at BTIG

TIPRANKS
·
Jul 02

Guardant rallies after UnitedHealth covers colorectal cancer test

TIPRANKS
·
Jul 01

Movement Alert|Guardant Health Rises 7.47% in Regular Trading, Bernstein Sees Revenue Upside From ADLT Pricing Qualification

Market Focus
·
Jul 01

Movement Alert|Guardant Health Pre-Market Rise 5.35%, Bernstein Sees Revenue Upside From ADLT Pricing Qualification

Market Focus
·
Jul 01

Guardant Health Co-ceo Amirali Talasaz Reports Disposal of Common Shares Worth $39.15 Million

Reuters
·
Jul 01

Crinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026

GlobeNewswire
·
Jul 01

Guardant Health is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 29

Movement Alert|Guardant Health Rises 5.08% in Regular Trading, Multiple Catalysts Continue to Drive Momentum

Market Focus
·
Jun 27

Guardant Health Price Target Announced at $175.00/share by Bernstein

Dow Jones
·
Jun 26

GH Research Shareholders Approve Director Slate and 2026 Auditor at June AGM

TIPRANKS
·
Jun 26

U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex

Reuters
·
Jun 26

Movement Alert|Guardant Health Rises 5.05% in Regular Trading, Multiple Catalysts Drive Continued Rally

Market Focus
·
Jun 25